Corcept Therapeutics Inc
CORT· Nasdaq
Released Nov 3, 2021, after the close
10-Q filed Nov 3, 2021, 34 days after period end · 0001628280-21-021485
| Metric | Q3 2021 | Q3 2020 | Q3 2019 | Q3 2018 |
|---|---|---|---|---|
| Revenue | $96.13M | $86.33M | $81.51M | $64.45M |
| Net Income | $30.47M | $21.63M | $26.34M | $17.75M |
| EPS Diluted |
Corcept Therapeutics Inc · CIK 1088856 · Engraved from SEC EDGAR
| $0.24 |
| $0.17 |
| $0.22 |
| $0.14 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.